2 results
Approved WMOCompleted
The objective of the study is demonstrate the safety and efficacy of the subcutaneous defibrillation system.
Approved WMOCompleted
Phase 1b:Primary:- To evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) and schedule of ALRN-6924 when administered to patients with TP53-mutated extensive disease (ED) small cell lung cancer (SCLC) receiving…